Macquarie Group Ltd dividend surges, what you need to know

Macquarie Group Ltd (ASX:MQG) has several qualities investors would do well to appreciate.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Asset manager and investment bank Macquarie Group Ltd (ASX: MQG) reported its earnings result for the half-year ending September 30 2016 (1H17) this morning. A summary of which is below:

  • 1H17 net profit of $1,050 million, down 2% on 1H16 and up 6% on 2H16
  • 1H17 operating income of $5,218 million, down 2% on 1H16 and up 8% on 2H16
  • 1H17 earnings per share (EPS) of $3.12, down 4% on 1H16 and up 6% on 2H16
  • 1H17 dividend of $1.95 per share, up 18.75% on 1H16 on a payout ratio of 62%
  • Annualised return on equity of 14.6%, down from 15.8% in 1H16
  • Around 70% of earnings in 1H17 came from asset management style activities
  • Forecast for full year FY17 earnings to be "broadly in line" with FY16

The result is ahead of analysts' expectations and the sharp lift in the dividend is likely to put the cat amongst the pigeons for analysts who were largely forecasting a minimal to flat rise. Income-hungry investors are also likely to applaud the move and if the group lifts FY16's final dividend ($2.40) by at least a double-digit amount then the stock is likely to be on a forward yield of 5.7% plus franking credits for FY17.

The valuation also remains reasonable on around 12.5x forward earnings assuming the group meets its own forecasts for FY17's earnings to be brodly in line with FY16. If the Australian dollar tracks lower over the six months to April 2017 on the back of U.S. economic strength the group is likely to receive a nice tailwind with around 60% of its total income earned overseas in H1 17.

Management's strategy

Macquarie is also continuing to shift its focus into the asset management space as regulators tighten their post-GFC grip on the regulation and leverage of investment and mainstream banks alike.

Due to new and expected capital adequacy regulations the Macquarie bankers are trying to move away from business operations that require a lot of capital such as lending and derivative trading in favour of asset management, as this is a relatively capital light business activity that offers the serendipitous bonus of more reliable fee streams.

It's also fortunate for investors that Macquarie's management woke up to the prospect of tightening capital adequacy regulations in good time and the bank has spent the past few years implementing its strategy to deleverage in response to toughening capital adequacy requirements. Another example of which is the sale of its capital-heavy life insurance business to Zurich over the reporting period. The sale directly supported the earnings result and should help demonstrate to investors why Macquarie is able to generate market-thumping returns for shareholders.

The problems facing the life insurance industry are no big secret and while groups like Macquarie have the dexterity to adapt by selling in order to improve their capital positions, others like AMP Limited (ASX: AMP) continue to post huge write downs (just today) as they don't have the operational competence of superior businesses.

Even the National Australia Bank Ltd (ASX: NAB) recently moved to sell its life insurance business after the penny dropped that regulators would not be backing down in terms of increased capital adequacy requirements. Consequently, NAB's shares lifted on yesterday's overall result, although really it should have sold or spun off its poorly-performing life insurance business several years ago.

Macquarie's Outlook

In my opinion Macquarie's solid management team and continuing shift into the asset management space are what means it is an attractive long-term investment. At $80.02 the shares look reasonable value and I would look to enter the stock by buying in parcels over a 6 to 18-month period in order to even out the effects of the inevitable volatility in global capital markets.

Motley Fool contributor Tom Richardson owns shares of Macquarie Group Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »